Hosle, Norway

Øyvind S Bruland

This inventor holds 1 USPTO granted patent. Top assignee: Anticancer Therapeutic Inventions as. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Øyvind S Bruland. Retrieved from https://idiyas.com/inventor/andoslashyvind-s-bruland

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Øyvind S Bruland: Innovator in Cancer Therapy

Introduction

Øyvind S Bruland is a notable inventor based in Hosle, Norway. He has made significant contributions to the field of cancer therapy, particularly in the treatment of bone cancer. His innovative approaches have garnered attention in the medical community.

Latest Patents

Bruland holds a patent for the preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioning. This patent describes processes for the preparation, prepared solutions, and the use of radium-223 for the treatment of calcified tumors, bone tumors, treatment of bones, bone surfaces, and soft tissues. His work in this area is crucial for improving patient outcomes in cancer treatment.

Career Highlights

Throughout his career, Øyvind S Bruland has been associated with Anticancer Therapeutic Inventions AS, where he has focused on developing innovative therapies for cancer patients. His dedication to research and development has positioned him as a key figure in the field of oncology.

Collaborations

Bruland has collaborated with notable professionals in his field, including Roy H Larsen and Gjermund Henriksen. These partnerships have enhanced his research efforts and contributed to the advancement of cancer therapies.

Conclusion

Øyvind S Bruland's work in cancer therapy, particularly through his patent on radium-223, showcases his commitment to improving treatment options for patients. His contributions continue to influence the field of oncology and inspire future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…